combination immunotherapy

3 trials

Sponsors

Yamaguchi university Graduate School of Medicine, Yamaguchi University, Yamaguchi University Graduate School of Medicine

Conditions

colorectal cancerhepatocellular carcinomasolid cancer

Phase 1

A combination immunotherapy for the patients with advanced or metastatic solid cancer

Active, not recruitingJPRN-UMIN000020440

Yamaguchi university Graduate School of Medicinesolid cancer

Start: 2016-01-05Target: 15Updated: 2026-06-29

A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancer

Active, not recruitingJPRN-UMIN000022082

Yamaguchi Universitycolorectal cancer

Start: 2016-04-01Target: 12Updated: 2026-06-29

A phase I study of combination adjuvant immunotherapy for patients with resectable hepatocellular carcinoma

Active, not recruitingJPRN-UMIN000029991

Yamaguchi University Graduate School of Medicinehepatocellular carcinoma

Start: 2018-01-01Target: 20Updated: 2026-06-29

Related Papers

Induction of antigen specific CD8+ T cell infiltration by a novel neoadjuvant vaccine containing HSP70 and GPC3 peptides plus soluble LAG-3 and Poly-IC:LC: Interim results of a Phase I study.

Journal of Clinical Oncology2019-05-201 citations

A phase I study of novel multi-HLA-binding peptides and a new combination of immune adjuvants against solid tumors.

Journal of Clinical Oncology2017-05-201 citations